Literature DB >> 20039446

Antibiotics and probiotics in chronic pouchitis: a comparative proteomic approach.

Silvia Turroni1, Beatrice Vitali, Marco Candela, Paolo Gionchetti, Fernando Rizzello, Massimo Campieri, Patrizia Brigidi.   

Abstract

AIM: To profile protein expression in mucosal biopsies from patients with chronic refractory pouchitis following antibiotic or probiotic treatment, using a comparative proteomic approach.
METHODS: Two-dimensional polyacrylamide gel electrophoresis and matrix-assisted laser desorption/ionization-time of flight mass spectrometry were used to characterize the changes related to antibiotic therapy in the protein expression profiles of biopsy samples from patients with chronic refractory pouchitis. The same proteomic approach was applied to identify differentially expressed proteins in the non-inflamed pouch before and after probiotic administration.
RESULTS: In the first set of 2D gels, 26 different proteins with at least 2-fold changes in their expression levels between the pouchitis condition and antibiotic-induced remission were identified. In the second set of analysis, the comparison between mucosal biopsy proteomes in the normal and probiotic-treated pouch resulted in 17 significantly differently expressed proteins. Of these, 8 exhibited the same pattern of deregulation as in the pouchitis/pouch remission group.
CONCLUSION: For the first time, 2D protein maps of mucosal biopsies from patients with ileal pouch-anal anastomosis were provided, and differentially expressed proteins following antibiotic/probiotic treatment were identified.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20039446      PMCID: PMC2799914          DOI: 10.3748/wjg.v16.i1.30

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  41 in total

1.  In-gel digestion for mass spectrometric characterization of proteins and proteomes.

Authors:  Andrej Shevchenko; Henrik Tomas; Jan Havlis; Jesper V Olsen; Matthias Mann
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

2.  Products formed during fermentation of the prebiotic inulin with human gut flora enhance expression of biotransformation genes in human primary colon cells.

Authors:  Julia Sauer; Konrad Klaus Richter; Beatrice Louise Pool-Zobel
Journal:  Br J Nutr       Date:  2007-05       Impact factor: 3.718

3.  Administration of Lactobacillus evokes coordinated changes in the intestinal expression profile of genes regulating energy homeostasis and immune phenotype in mice.

Authors:  Annika Nerstedt; Elisabeth C Nilsson; Kajsa Ohlson; Janet Håkansson; L Thomas Svensson; Björn Löwenadler; Ulla K Svensson; Margit Mahlapuu
Journal:  Br J Nutr       Date:  2007-04-16       Impact factor: 3.718

4.  Differential expression of mimecan and thioredoxin domain-containing protein 5 in colorectal adenoma and cancer: a proteomic study.

Authors:  Yinghong Wang; Yu Ma; Bingjian Lü; Enping Xu; Qiong Huang; Maode Lai
Journal:  Exp Biol Med (Maywood)       Date:  2007-10

5.  2-DE and MS analysis of interactions between Lactobacillus fermentum I5007 and intestinal epithelial cells.

Authors:  Fang Yang; Junjun Wang; Xiaojie Li; Tianyi Ying; Shiyan Qiao; Defa Li; Guoyao Wu
Journal:  Electrophoresis       Date:  2007-12       Impact factor: 3.535

6.  Altered expression of CK7 and CK20 in preneoplastic and neoplastic lesions in ulcerative colitis.

Authors:  Roger Stenling; Jan Lindberg; Jörgen Rutegård; Richard Palmqvist
Journal:  APMIS       Date:  2007-11       Impact factor: 3.205

Review 7.  Intestinal epithelial cell signalling and chronic inflammation: From the proteome to specific molecular mechanisms.

Authors:  Tanja Werner; Dirk Haller
Journal:  Mutat Res       Date:  2007-06-02       Impact factor: 2.433

Review 8.  Pouch-ouch.

Authors:  Elana A Maser; Daniel H Present
Journal:  Curr Opin Gastroenterol       Date:  2008-01       Impact factor: 3.287

9.  Comparative proteomic analysis of cell lines and scrapings of the human intestinal epithelium.

Authors:  Kaatje Lenaerts; Freek G Bouwman; Wouter H Lamers; Johan Renes; Edwin C Mariman
Journal:  BMC Genomics       Date:  2007-04-03       Impact factor: 3.969

10.  Probiotic modulation of symbiotic gut microbial-host metabolic interactions in a humanized microbiome mouse model.

Authors:  Francois-Pierre J Martin; Yulan Wang; Norbert Sprenger; Ivan K S Yap; Torbjörn Lundstedt; Per Lek; Serge Rezzi; Ziad Ramadan; Peter van Bladeren; Laurent B Fay; Sunil Kochhar; John C Lindon; Elaine Holmes; Jeremy K Nicholson
Journal:  Mol Syst Biol       Date:  2008-01-15       Impact factor: 11.429

View more
  5 in total

Review 1.  Diagnosis and management of pouchitis and ileoanal pouch dysfunction.

Authors:  Udayakumar Navaneethan; Bo Shen
Journal:  Curr Gastroenterol Rep       Date:  2010-12

Review 2.  Probiotics for the treatment of inflammatory bowel disease.

Authors:  Ganesh R Veerappan; John Betteridge; Patrick E Young
Journal:  Curr Gastroenterol Rep       Date:  2012-08

3.  Protective effects of Lactobacillus plantarum against epithelial barrier dysfunction of human colon cell line NCM460.

Authors:  Zhi-Hua Liu; Tong-Yi Shen; Peng Zhang; Yan-Lei Ma; Mary Pat Moyer; Huan-Long Qin
Journal:  World J Gastroenterol       Date:  2010-12-07       Impact factor: 5.742

4.  Comparative analysis of inflamed and non-inflamed colon biopsies reveals strong proteomic inflammation profile in patients with ulcerative colitis.

Authors:  Nina Aagaard Poulsen; Vibeke Andersen; Jens Christian Møller; Hanne Søndergaard Møller; Flemming Jessen; Stig Purup; Lotte Bach Larsen
Journal:  BMC Gastroenterol       Date:  2012-06-24       Impact factor: 3.067

5.  A natural-like synthetic small molecule impairs bcr-abl signaling cascades and induces megakaryocyte differentiation in erythroleukemia cells.

Authors:  Silvia Turroni; Manlio Tolomeo; Gianfranco Mamone; Gianluca Picariello; Elisa Giacomini; Patrizia Brigidi; Marinella Roberti; Stefania Grimaudo; Rosaria Maria Pipitone; Antonietta Di Cristina; Maurizio Recanatini
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.